Trial Outcomes & Findings for Strength for U in Relationship Empowerment (NCT NCT04218864)

NCT ID: NCT04218864

Last Updated: 2025-08-01

Results Overview

The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

122 participants

Primary outcome timeframe

Baseline, 6-week follow-up, 3, 6, and 12-month follow-up.

Results posted on

2025-08-01

Participant Flow

Participant milestones

Participant milestones
Measure
Strength for U in Relationship Empowerment (SURE)
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Overall Study
STARTED
65
57
Overall Study
COMPLETED
56
50
Overall Study
NOT COMPLETED
9
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Strength for U in Relationship Empowerment (SURE)
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Overall Study
Lost to Follow-up
8
4
Overall Study
Withdrawal by Subject
1
3

Baseline Characteristics

Strength for U in Relationship Empowerment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Strength for U in Relationship Empowerment (SURE)
n=65 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Total
n=122 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
65 Participants
n=5 Participants
57 Participants
n=7 Participants
122 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex/Gender, Customized
Female
65 Participants
n=5 Participants
57 Participants
n=7 Participants
122 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants
n=5 Participants
13 Participants
n=7 Participants
25 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants
n=5 Participants
44 Participants
n=7 Participants
97 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Caucasian/White
45 Participants
n=5 Participants
33 Participants
n=7 Participants
78 Participants
n=5 Participants
Race/Ethnicity, Customized
Black
13 Participants
n=5 Participants
16 Participants
n=7 Participants
29 Participants
n=5 Participants
Race/Ethnicity, Customized
Bi-Racial or Multi-Ethnic
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Race/Ethnicity, Customized
Native American or Native Alaskan
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=5 Participants
5 Participants
n=7 Participants
6 Participants
n=5 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
65 Participants
n=5 Participants
57 Participants
n=7 Participants
122 Participants
n=5 Participants
Sex: Female, Male
Female
65 Participants
n=5 Participants
57 Participants
n=7 Participants
122 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up.

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

Outcome measures

Outcome measures
Measure
Strength for U in Relationship Empowerment (SURE)
n=64 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Composite Abuse Scale (CAS)
6-week follow-up
10.54 units on a scale
Standard Deviation 12.02
10.02 units on a scale
Standard Deviation 12.78
Composite Abuse Scale (CAS)
Baseline
29.13 units on a scale
Standard Deviation 20.92
27.01 units on a scale
Standard Deviation 20.65
Composite Abuse Scale (CAS)
3-month follow-up
9.69 units on a scale
Standard Deviation 10.39
8.27 units on a scale
Standard Deviation 11.06
Composite Abuse Scale (CAS)
6-month follow-up
8.89 units on a scale
Standard Deviation 12.06
8.7 units on a scale
Standard Deviation 10.95
Composite Abuse Scale (CAS)
12-month follow-up
11.45 units on a scale
Standard Deviation 14.56
7.5 units on a scale
Standard Deviation 12.02

SECONDARY outcome

Timeframe: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

Positive affect and well-being will be measured by using the National Institutes of Health Quality of Life in Neurological Disorders scale for Positive Affect and Well-being a computerized adaptive test 9-item scale. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 9-45. Higher scores indicate higher positive affect, life satisfaction, or an overall sense of purpose and meaning. Change scores will be used to estimate differences within and between groups.

Outcome measures

Outcome measures
Measure
Strength for U in Relationship Empowerment (SURE)
n=64 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
The Positive Affect and Well-being Scale (PAW)
12-month follow-up
33.59 units on a scale
Standard Deviation 5.75
32.93 units on a scale
Standard Deviation 6.64
The Positive Affect and Well-being Scale (PAW)
Baseline
29.39 units on a scale
Standard Deviation 7.32
29.95 units on a scale
Standard Deviation 7.17
The Positive Affect and Well-being Scale (PAW)
6-week follow-up
31.68 units on a scale
Standard Deviation 6.43
32.05 units on a scale
Standard Deviation 6.68
The Positive Affect and Well-being Scale (PAW)
3-month follow-up
33.21 units on a scale
Standard Deviation 5.91
31.4 units on a scale
Standard Deviation 6.84
The Positive Affect and Well-being Scale (PAW)
6-month follow-up
32.64 units on a scale
Standard Deviation 6.08
30.84 units on a scale
Standard Deviation 6.51

SECONDARY outcome

Timeframe: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

Perceived emotional support will be measured using a 4-item scale developed by the Patient-Reported Outcomes Measurement Information System . Patient-Reported Outcomes Measurement Information System is a National Institutes of Health Roadmap initiative that provides precise, reliable, valid, and standardized questionnaires measuring patient-reported outcomes across the domains of physical, mental, and social health. The Patient-Reported Outcomes Measurement Information System .Emotional Support item bank specifically aims to measure perceived feelings of being cared for and valued as a person. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 4-20. A higher Patient-Reported Outcomes Measurement Information System score represents increased emotional support. Change scores will be used to estimate differences within and between groups.

Outcome measures

Outcome measures
Measure
Strength for U in Relationship Empowerment (SURE)
n=64 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Perceived Emotional Support (PES)
Baseline
14.61 units on a scale
Standard Deviation 4.15
14.89 units on a scale
Standard Deviation 4.16
Perceived Emotional Support (PES)
6- Week
15.41 units on a scale
Standard Deviation 3.63
15.32 units on a scale
Standard Deviation 4.23
Perceived Emotional Support (PES)
3- Month
15.75 units on a scale
Standard Deviation 3.45
14.77 units on a scale
Standard Deviation 4.46
Perceived Emotional Support (PES)
6- Month
15.15 units on a scale
Standard Deviation 3.54
15.12 units on a scale
Standard Deviation 3.49
Perceived Emotional Support (PES)
12-Month
16.02 units on a scale
Standard Deviation 3.67
15.58 units on a scale
Standard Deviation 4

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

Empowerment will be measured using the Personal Progress Scale-Revised for measuring skills, social supports, and resources to cope more effectively with relationship stress and trauma. The Personal Progress Scale-Revised is a 28-item scale scored between 1 and 7, with 1=Almost Never and 7=Almost Always. Scale range is from 28-196. Higher scores indicating higher empowerment. Change scores will be used to estimate differences within and between groups.

Outcome measures

Outcome measures
Measure
Strength for U in Relationship Empowerment (SURE)
n=64 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Personal Progress Scale-Revised (PPS-R)
3-Month
111.4 units on a scale
Standard Deviation 13.4
113.74 units on a scale
Standard Deviation 14.11
Personal Progress Scale-Revised (PPS-R)
Baseline
129.53 units on a scale
Standard Deviation 21.66
132.56 units on a scale
Standard Deviation 22.62
Personal Progress Scale-Revised (PPS-R)
6-Week
109.08 units on a scale
Standard Deviation 14.39
113.66 units on a scale
Standard Deviation 11.72
Personal Progress Scale-Revised (PPS-R)
6-Month
111.42 units on a scale
Standard Deviation 14.01
113.84 units on a scale
Standard Deviation 14.11
Personal Progress Scale-Revised (PPS-R)
12-Month
114.1 units on a scale
Standard Deviation 16.44
110.87 units on a scale
Standard Deviation 12.03

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

Self-efficacy will be measured using the General Self-Efficacy Scale a 10-item self-report measure. It measures personal competence to deal effectively with a variety of stressful situations. The General Self-Efficacy Scale is scored from 10-40, with 1=Not at all true and 4=Exactly true. A higher score indicates more self-efficacy. Change scores will be used to estimate differences within and between groups.

Outcome measures

Outcome measures
Measure
Strength for U in Relationship Empowerment (SURE)
n=64 Participants
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 Participants
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Self-efficacy (GSE)
Baseline
28.45 units on a scale
Standard Deviation 4.57
27.34 units on a scale
Standard Deviation 4.8
Self-efficacy (GSE)
6- Week
28.71 units on a scale
Standard Deviation 4.17
28.68 units on a scale
Standard Deviation 5.23
Self-efficacy (GSE)
3- Month
29.67 units on a scale
Standard Deviation 3.82
29.57 units on a scale
Standard Deviation 5.32
Self-efficacy (GSE)
6- Month
29.49 units on a scale
Standard Deviation 4.23
28.84 units on a scale
Standard Deviation 4.58
Self-efficacy (GSE)
12-Month
30.72 units on a scale
Standard Deviation 3.94
29.79 units on a scale
Standard Deviation 4.7

Adverse Events

Strength for U in Relationship Empowerment (SURE)

Serious events: 24 serious events
Other events: 0 other events
Deaths: 0 deaths

Attention, Time, and Information Matched Control

Serious events: 17 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Strength for U in Relationship Empowerment (SURE)
n=65 participants at risk
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, Time, and Information Matched Control
n=57 participants at risk
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Pregnancy, puerperium and perinatal conditions
Hospitalization
4.6%
3/65 • Number of events 3 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
1.8%
1/57 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Renal and urinary disorders
Hospitalization
3.1%
2/65 • Number of events 2 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
1.8%
1/57 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Social circumstances
IPV Altercation (non-study related)
23.1%
15/65 • Number of events 37 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
15.8%
9/57 • Number of events 19 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Psychiatric disorders
Hospitalization
3.1%
2/65 • Number of events 3 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
7.0%
4/57 • Number of events 4 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Social circumstances
Housing
1.5%
1/65 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
1.8%
1/57 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Infections and infestations
Hospitalization
1.5%
1/65 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
0.00%
0/57 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
Ear and labyrinth disorders
Hospitalization
0.00%
0/65 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.
1.8%
1/57 • Number of events 1 • Adverse event data were collected at 6-weeks, 3-months, 6 months , and 12-months after baseline assessment
Systematic assessment: The study research staff conducted a standard structured interview at each follow-up period. Specific pregnancy-related medical conditions resulting in hospitalization were not evaluated.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Caron Zlotnick

Women & Infants Hospital

Phone: 4014743332

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place